Skip to content

Clinical trials

Phase 2 Small Cell Lung Carcinoma trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 2 Country / region: Poland Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20081
20111
20121
20142
20201
20214
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Celgene2
Eli Lilly and Company2
AbbVie1
Amgen1
Astex Pharmaceuticals, Inc.1
AstraZeneca1
Bayer1
GlaxoSmithKline1
MacroGenics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma16
Carcinoma, Non-Small-Cell Lung3
Lung Neoplasms2
Anus Neoplasms1
Carcinoma, Small Cell1
Melanoma1
Neoplasms1
Prostatic Neoplasms, Castration-Resistant1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.